Garret FitzGerald, MD, McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania School of Medicine; Chair of the Department of Pharmacology; and Director of the Institute for Translational Medicine and Therapeutics received the J. Allyn Taylor International Prize in Medicine last month. Supported by the Robarts Research Institute at The University of Western Ontario, the award annually recognizes the world’s leading medical researcher. FitzGerald was recognized for his contributions to the development of low-dose aspirin for the prevention of heart disease and being the first investigator to predict and explain the cardiovascular hazard from nonsteroidal anti-inflammatory drugs.

For more information, see the University of Western Ontario News Release.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.